Aerrane(Isoflurane), sold under the trade name Forane among others, is a general anesthetic. It can be used to start or maintain anesthesia.
In 2019, the market size of Aerrane is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Aerrane.
This report studies the global market size of Aerrane, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Aerrane sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Baxter
AbbVie
Halocarbon
Piramal Critical Care
Aesica Queenborough
Abbott Laboratories
Toronto Research Chemicals
Abcam
VetOne
MedKoo Biosciences
JD Medical
Lunan Pharmaceutical Group
Market Segment by Product Type
Above 100ml
100-250ml
Above 250ml
Market Segment by Application
Hospital
Clinic
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Aerrane status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Aerrane manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Aerrane are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
In 2019, the market size of Aerrane is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Aerrane.
This report studies the global market size of Aerrane, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Aerrane sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Baxter
AbbVie
Halocarbon
Piramal Critical Care
Aesica Queenborough
Abbott Laboratories
Toronto Research Chemicals
Abcam
VetOne
MedKoo Biosciences
JD Medical
Lunan Pharmaceutical Group
Market Segment by Product Type
Above 100ml
100-250ml
Above 250ml
Market Segment by Application
Hospital
Clinic
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Aerrane status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Aerrane manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Aerrane are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Aerrane Market Size Growth Rate by Type (2019-2025)
1.3.2 Above 100ml
1.3.3 100-250ml
1.3.4 Above 250ml
1.4 Market Segment by Application
1.4.1 Global Aerrane Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aerrane Market Size
2.1.1 Global Aerrane Revenue 2014-2025
2.1.2 Global Aerrane Sales 2014-2025
2.2 Aerrane Growth Rate by Regions
2.2.1 Global Aerrane Sales by Regions 2014-2019
2.2.2 Global Aerrane Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Aerrane Sales by Manufacturers
3.1.1 Aerrane Sales by Manufacturers 2014-2019
3.1.2 Aerrane Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Aerrane Revenue by Manufacturers (2014-2019)
3.2.2 Aerrane Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Aerrane Market Concentration Ratio (CR5 and HHI)
3.3 Aerrane Price by Manufacturers
3.4 Key Manufacturers Aerrane Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Aerrane Market
3.6 Key Manufacturers Aerrane Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Above 100ml Sales and Revenue (2014-2019)
4.1.2 100-250ml Sales and Revenue (2014-2019)
4.1.3 Above 250ml Sales and Revenue (2014-2019)
4.2 Global Aerrane Sales Market Share by Type
4.3 Global Aerrane Revenue Market Share by Type
4.4 Aerrane Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Aerrane Sales by Application
6 United States
6.1 United States Aerrane Breakdown Data by Company
6.2 United States Aerrane Breakdown Data by Type
6.3 United States Aerrane Breakdown Data by Application
7 European Union
7.1 European Union Aerrane Breakdown Data by Company
7.2 European Union Aerrane Breakdown Data by Type
7.3 European Union Aerrane Breakdown Data by Application
8 China
8.1 China Aerrane Breakdown Data by Company
8.2 China Aerrane Breakdown Data by Type
8.3 China Aerrane Breakdown Data by Application
9 Rest of World
9.1 Rest of World Aerrane Breakdown Data by Company
9.2 Rest of World Aerrane Breakdown Data by Type
9.3 Rest of World Aerrane Breakdown Data by Application
9.4 Rest of World Aerrane Breakdown Data by Countries
9.4.1 Rest of World Aerrane Sales by Countries
9.4.2 Rest of World Aerrane Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Aerrane
10.1.4 Aerrane Product Introduction
10.1.5 Baxter Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Aerrane
10.2.4 Aerrane Product Introduction
10.2.5 AbbVie Recent Development
10.3 Halocarbon
10.3.1 Halocarbon Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Aerrane
10.3.4 Aerrane Product Introduction
10.3.5 Halocarbon Recent Development
10.4 Piramal Critical Care
10.4.1 Piramal Critical Care Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Aerrane
10.4.4 Aerrane Product Introduction
10.4.5 Piramal Critical Care Recent Development
10.5 Aesica Queenborough
10.5.1 Aesica Queenborough Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Aerrane
10.5.4 Aerrane Product Introduction
10.5.5 Aesica Queenborough Recent Development
10.6 Abbott Laboratories
10.6.1 Abbott Laboratories Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Aerrane
10.6.4 Aerrane Product Introduction
10.6.5 Abbott Laboratories Recent Development
10.7 Toronto Research Chemicals
10.7.1 Toronto Research Chemicals Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Aerrane
10.7.4 Aerrane Product Introduction
10.7.5 Toronto Research Chemicals Recent Development
10.8 Abcam
10.8.1 Abcam Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Aerrane
10.8.4 Aerrane Product Introduction
10.8.5 Abcam Recent Development
10.9 VetOne
10.9.1 VetOne Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Aerrane
10.9.4 Aerrane Product Introduction
10.9.5 VetOne Recent Development
10.10 MedKoo Biosciences
10.10.1 MedKoo Biosciences Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Aerrane
10.10.4 Aerrane Product Introduction
10.10.5 MedKoo Biosciences Recent Development
10.11 JD Medical
10.12 Lunan Pharmaceutical Group
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Aerrane Sales Channels
11.2.2 Aerrane Distributors
11.3 Aerrane Customers
12 Market Forecast
12.1 Global Aerrane Sales and Revenue Forecast 2019-2025
12.2 Global Aerrane Sales Forecast by Type
12.3 Global Aerrane Sales Forecast by Application
12.4 Aerrane Forecast by Regions
12.4.1 Global Aerrane Sales Forecast by Regions 2019-2025
12.4.2 Global Aerrane Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Aerrane Market Size Growth Rate by Type (2019-2025)
1.3.2 Above 100ml
1.3.3 100-250ml
1.3.4 Above 250ml
1.4 Market Segment by Application
1.4.1 Global Aerrane Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aerrane Market Size
2.1.1 Global Aerrane Revenue 2014-2025
2.1.2 Global Aerrane Sales 2014-2025
2.2 Aerrane Growth Rate by Regions
2.2.1 Global Aerrane Sales by Regions 2014-2019
2.2.2 Global Aerrane Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Aerrane Sales by Manufacturers
3.1.1 Aerrane Sales by Manufacturers 2014-2019
3.1.2 Aerrane Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Aerrane Revenue by Manufacturers (2014-2019)
3.2.2 Aerrane Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Aerrane Market Concentration Ratio (CR5 and HHI)
3.3 Aerrane Price by Manufacturers
3.4 Key Manufacturers Aerrane Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Aerrane Market
3.6 Key Manufacturers Aerrane Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Above 100ml Sales and Revenue (2014-2019)
4.1.2 100-250ml Sales and Revenue (2014-2019)
4.1.3 Above 250ml Sales and Revenue (2014-2019)
4.2 Global Aerrane Sales Market Share by Type
4.3 Global Aerrane Revenue Market Share by Type
4.4 Aerrane Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Aerrane Sales by Application
6 United States
6.1 United States Aerrane Breakdown Data by Company
6.2 United States Aerrane Breakdown Data by Type
6.3 United States Aerrane Breakdown Data by Application
7 European Union
7.1 European Union Aerrane Breakdown Data by Company
7.2 European Union Aerrane Breakdown Data by Type
7.3 European Union Aerrane Breakdown Data by Application
8 China
8.1 China Aerrane Breakdown Data by Company
8.2 China Aerrane Breakdown Data by Type
8.3 China Aerrane Breakdown Data by Application
9 Rest of World
9.1 Rest of World Aerrane Breakdown Data by Company
9.2 Rest of World Aerrane Breakdown Data by Type
9.3 Rest of World Aerrane Breakdown Data by Application
9.4 Rest of World Aerrane Breakdown Data by Countries
9.4.1 Rest of World Aerrane Sales by Countries
9.4.2 Rest of World Aerrane Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Aerrane
10.1.4 Aerrane Product Introduction
10.1.5 Baxter Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Aerrane
10.2.4 Aerrane Product Introduction
10.2.5 AbbVie Recent Development
10.3 Halocarbon
10.3.1 Halocarbon Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Aerrane
10.3.4 Aerrane Product Introduction
10.3.5 Halocarbon Recent Development
10.4 Piramal Critical Care
10.4.1 Piramal Critical Care Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Aerrane
10.4.4 Aerrane Product Introduction
10.4.5 Piramal Critical Care Recent Development
10.5 Aesica Queenborough
10.5.1 Aesica Queenborough Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Aerrane
10.5.4 Aerrane Product Introduction
10.5.5 Aesica Queenborough Recent Development
10.6 Abbott Laboratories
10.6.1 Abbott Laboratories Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Aerrane
10.6.4 Aerrane Product Introduction
10.6.5 Abbott Laboratories Recent Development
10.7 Toronto Research Chemicals
10.7.1 Toronto Research Chemicals Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Aerrane
10.7.4 Aerrane Product Introduction
10.7.5 Toronto Research Chemicals Recent Development
10.8 Abcam
10.8.1 Abcam Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Aerrane
10.8.4 Aerrane Product Introduction
10.8.5 Abcam Recent Development
10.9 VetOne
10.9.1 VetOne Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Aerrane
10.9.4 Aerrane Product Introduction
10.9.5 VetOne Recent Development
10.10 MedKoo Biosciences
10.10.1 MedKoo Biosciences Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Aerrane
10.10.4 Aerrane Product Introduction
10.10.5 MedKoo Biosciences Recent Development
10.11 JD Medical
10.12 Lunan Pharmaceutical Group
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Aerrane Sales Channels
11.2.2 Aerrane Distributors
11.3 Aerrane Customers
12 Market Forecast
12.1 Global Aerrane Sales and Revenue Forecast 2019-2025
12.2 Global Aerrane Sales Forecast by Type
12.3 Global Aerrane Sales Forecast by Application
12.4 Aerrane Forecast by Regions
12.4.1 Global Aerrane Sales Forecast by Regions 2019-2025
12.4.2 Global Aerrane Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
